Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$63,380.00
Jan 1, 2027
For-profit organization
UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies
1034675
As part of the international consortium project “UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies”, this project's objective is to use Chromatin Bio's bioinformatics platform to design novel gene regulatory elements, improving gene expression in Mediphage therapeutic constructs for Stargardt disease, while reducing sequence complexity and increasing manufacturing yields.
$6,800.00
Jun 23, 2026
For-profit organization
IP Assist: Intellectual Property Strategy Engagement for Virtual Caregiver
1044032
The project will support development of intellectual property capacity within the firm.
$30,000.00
Jun 15, 2026
For-profit organization
Youth AI-Assisted Genomic Workflow Development and Clinical Program Coordination (YEP)
1044127
PhenoTips (Gene42 Inc.) develops clinical genomics software used by hospital genetics programs across Canada, the UK, and Europe.
$144,000.00
Jun 1, 2026
For-profit organization
Advancing a Selective EGFR-TKI Inhibitor to Overcome Drug Resistance in Lung Cancer
1043904
Rane Pharmaceutical is developing novel small molecule therapy to treat drug resistant Non-Small Cell Lung Cancer (NSCLC).
$200,000.00
Jun 1, 2026
For-profit organization
Development of an AI-Enabled Light Therapy Solution
1044498
The project is focused on developing and testing a direct retinal photobiomodulation system that uses targeted light delivery, automated dosing and AI-supported imaging.
$64,083.00
May 20, 2026
For-profit organization
Expansion of trevii capability for in-home patient therapy management
1043088
The plan is to use the trevii hardware to detect the start, duration, and stop times that patients are using the medical device for in-home patients. By reconciling this therapy data with clinical and operational hospital staff, can achieve significant cost savings opportunities.
$30,000.00
May 19, 2026
For-profit organization
Youth: Research Assisstant in virus production
1043205
Research and development in virus-like particles for uses with in vivo cell therapy applications.
$497,773.00
May 14, 2026
Academia
Transforming Insomnia Care: Deployment of CBT-I in a Mobile Application
1042512
To address these challenges, we will integrate a validated sleep intervention - cognitive-behavioral therapy for insomnia (eCBTi+) - from CRIUGM’s e-SPACE web platform into DigiSensing, a digital phenotyping platform and smartphone application developed at NRC.
$145,600.00
May 1, 2026
For-profit organization
Development of a Novel Nasal Cannula Device to Improve Portable Oxygen Therapy
1042382
Pulmvita Inc. is an Edmonton-based medical device company developing a novel nasal cannula to improve the reliability and efficiency of portable oxygen therapy. The device uses proprietary breath-detection technology and a nasal pillows seal to ensure consistent oxygen delivery during various activities, including sleep and exercise.
$600,000.00
May 1, 2026
For-profit organization
CIIP Singapore - PEGASUS-BPE-CAR-T: Cost-Effective CAR-TCR Development with Pegasus Bio's BPE Plasmid Platform
1043376
CIIP Singapore -PEGASUS-BPE-CAR-T: Cell and gene therapy manufacturing faces major bottlenecks due to low-yield, high-cost, and difficult-to-scale plasmid DNA systems that limit efficient viral production.